CardioGenics Holdings Financials
| CGNH Stock | USD 0.0001 0.00 0.00% |
CardioGenics |
Understanding current and past CardioGenics Holdings Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CardioGenics Holdings' financial statements are interrelated, with each one affecting the others. For example, an increase in CardioGenics Holdings' assets may result in an increase in income on the income statement.
CardioGenics Holdings Stock Summary
CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. The company was founded in 1997 and is headquartered in Mississauga, Canada. Cardiogenics Holdings operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 4 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 6295 Northam Drive, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.cardiogenics.com |
| Phone | 905 673 8501 |
| Currency | USD - US Dollar |
CardioGenics Holdings Key Financial Ratios
CardioGenics Holdings' financial ratios allow both analysts and investors to convert raw data from CardioGenics Holdings' financial statements into concise, actionable information that can be used to evaluate the performance of CardioGenics Holdings over time and compare it to other companies across industries.| Return On Asset | -1.15 | |||
| Target Price | 2.0 | |||
| Beta | 97.17 |
CardioGenics Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CardioGenics Holdings's current stock value. Our valuation model uses many indicators to compare CardioGenics Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CardioGenics Holdings competition to find correlations between indicators driving CardioGenics Holdings's intrinsic value. More Info.CardioGenics Holdings is rated second in return on asset category among its peers. It is rated fourth in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value CardioGenics Holdings by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CardioGenics Holdings' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.CardioGenics Holdings Systematic Risk
CardioGenics Holdings' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CardioGenics Holdings volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on CardioGenics Holdings correlated with the market. If Beta is less than 0 CardioGenics Holdings generally moves in the opposite direction as compared to the market. If CardioGenics Holdings Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CardioGenics Holdings is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CardioGenics Holdings is generally in the same direction as the market. If Beta > 1 CardioGenics Holdings moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for CardioGenics Pink Sheet analysis
When running CardioGenics Holdings' price analysis, check to measure CardioGenics Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CardioGenics Holdings is operating at the current time. Most of CardioGenics Holdings' value examination focuses on studying past and present price action to predict the probability of CardioGenics Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CardioGenics Holdings' price. Additionally, you may evaluate how the addition of CardioGenics Holdings to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |